22.05.2022 Views

DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

necessary. Rifabutin, if used in conjunction with clarithromycin

or fluconazole for treatment of Mycobacterium avium complex

(MAC) opportunistic infections in human immunodeficiency

virus (HIV)-positive persons, is associated with an iridocyclitis

and even hypopyon. This will resolve with steroids or by stopping

the medication.

Ocular Surface. Isotretinoin (ACCUTANE, others) has a drying effect

on mucous membranes and is associated with dry eye and meibomian

gland dysfunction.

Cornea Coryanghiva and Eyclids . The cornea, the conjunctiva, and

even the eyelids can be affected by systemic medications. One of

the most common drug deposits found in the cornea is from the cardiac

medication amiodarone. It deposits in the inferior and central

cornea in a whorl-like pattern termed cornea verticillata. It appears

as fine tan or brown pigment in the epithelium. Fortunately, the

deposits seldom affect vision, and therefore, this rarely is a cause to

discontinue the medication. The deposits disappear slowly if the

medication is stopped. Other medications, including indomethacin,

atovaquone, chloroquine, and hydroxychloroquine, can cause a similar

pattern.

The phenothiazines, including chlorpromazine and thioridazine,

can cause brown pigmentary deposits in the cornea, conjunctiva,

and eyelids. The deposits generally are found in

Descemet’s membrane and the posterior cornea. They typically do

not affect vision. The ocular deposits generally persist after discontinuation

of the medication and can even worsen, perhaps because

the medication deposits in the skin are slowly released and accumulate

in the eye.

Gold treatments for arthritis (now rarely used) can lead to gold

deposition in the cornea and conjunctiva, which are termed chrysiasis

and are gold to violet in color. With lower cumulative doses (1-2 g),

the deposits are found primarily in the epithelium and anterior stroma.

These deposits usually disappear with discontinuation of the medication.

With higher doses, the gold is deposited in Descemet’s membrane

and posterior stroma and can involve the entire stroma. These

changes can be permanent. The deposits generally do not affect vision

and are not a reason to stop gold therapy.

Tetracyclines can cause a yellow discoloration of the lightexposed

conjunctiva. Systemic minocycline can induce a blue-gray

scleral pigmentation that is most prominent in the interpalpebral

zone (Morrow and Abbott, 1998).

Agents Used to Assist

in Ocular Diagnosis

A number of agents are used in an ocular examination

(e.g., mydriatic agents, topical anesthetics, dyes to evaluate

corneal surface integrity), to facilitate intraocular

surgery (e.g., mydriatic and miotic agents, topical and

local anesthetics), and to help in making a diagnosis in

cases of anisocoria (Figure 64–5) and retinal abnormalities

(e.g., intravenous contrast agents). The autonomic

agents have been discussed earlier. The diagnostic and

therapeutic uses of topical and intravenous dyes and of

topical anesthetics are discussed in “Anterior Segment

and External Diagnostic Uses” and “Posterior Segment

Diagnostic Uses.”

Anterior Segment and External Diagnostic Uses. Epiphora (excessive

tearing) and surface problems of the cornea and conjunctiva

are commonly encountered external ocular disorders. The dyes fluorescein,

rose bengal, and lissamine green are used in evaluating

these problems. Available as a 2% alkaline solution, 10% and 25%

solutions for injection, and an impregnated paper strip, fluorescein

reveals epithelial defects of the cornea and conjunctiva and aqueous

humor leakage that may occur after trauma or ocular surgery.

In the setting of epiphora, fluorescein is used to help determine the

patency of the nasolacrimal system. In addition, this dye is used

as part of the procedure of applanation tonometry (IOP measurement)

and to assist in determining the proper fit of rigid and semirigid

contact lenses. Fluorescein in combination with proparacaine

or benoxinate is available for procedures in which a disclosing

agent is needed in conjunction with a topical anesthetic. Fluorexon

(FLUORESOFT), a high-molecular-weight fluorescent solution, is

used when fluorescein is contraindicated (as when soft contact

lenses are in place).

Rose bengal and lissamine green, available as saturated paper

strips, stain devitalized tissue on the cornea and conjunctiva.

Posterior Segment Diagnostic Uses. The integrity of the blood-retinal

and retinal pigment epithelial barriers may be examined directly by

retinal angiography using intravenous administration of either fluorescein

sodium or indocyanine green. These agents commonly cause

nausea and may precipitate serious allergic reactions in susceptible

individuals.

Agents Used to Treat Retinal

Neovascularization and Macular

Degeneration

Verteporfin (VISUDYNE) is approved for photodynamic

therapy of the exudative form of ARMD with predominantly

classic choroidal neovascular membranes (Fine

et al., 2000; Jager et al., 2008). Verteporfin also is used in

the treatment of predominantly classic choroidal neovascularization

caused by conditions such as pathological

1793

CHAPTER 64

OCULAR PHARMACOLOGY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!